SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

Biomea Fusion, Inc.
Date: Aug. 13, 2025 · CIK: 0001840439 · Accession: 0001193125-25-179812

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-289262

Date
August 13, 2025
Author
By
Form
CORRESP
Company
Biomea Fusion, Inc.

Letter

Re:

Biomea Fusion, Inc. 1599 Industrial Road San Carlos, CA 94070 August 13, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance – Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549

Biomea Fusion, Inc. Registration Statement on Form S-3 File No. 333-289262 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Biomea Fusion, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-289262) (the “Registration Statement”), so that it may become effective at 4:01 pm Eastern time on August 15, 2025, or as soon thereafter as practicable.

Very truly yours,
BIOMEA FUSION, INC.
By:

Show Raw Text
CORRESP
 1
 filename1.htm

 CORRESP

 Biomea Fusion, Inc.
 1599 Industrial Road San Carlos,
CA 94070 August 13, 2025 VIA EDGAR
 Securities and Exchange Commission Division of
Corporation Finance – Office of Life Sciences 100 F Street, N.E.
 Washington, D.C. 20549

 Re:

 Biomea Fusion, Inc. Registration Statement on
Form S-3 File No. 333-289262
 Request for Acceleration
 Ladies and Gentlemen:
 Pursuant to Rule 461 under the Securities Act of 1933, as amended, Biomea Fusion, Inc. hereby requests acceleration of the effective date of
its Registration Statement on Form S-3 (File No. 333-289262) (the “Registration Statement”), so that it may become effective at 4:01 pm Eastern time on August 15, 2025, or as soon
thereafter as practicable.

 Very truly yours,
 BIOMEA FUSION, INC.

 By:

 /s/ Michael J.M. Hitchcock, Ph.D.

 Name: Michael J.M. Hitchcock, Ph.D.

 Title: Interim Chief Executive Officer and Director

 Cc:
 Maggie Wong, Goodwin Procter LLP

  
 Alicia Tschirhart, Goodwin Procter LLP